IRIS Accounts Production v26.1.10.61 05542912 Board of Directors 1.4.25 31.3.26 31.3.26 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh055429122025-03-31055429122026-03-31055429122025-04-012026-03-31055429122024-03-31055429122024-04-012025-03-31055429122025-03-3105542912ns15:EnglandWales2025-04-012026-03-3105542912ns14:PoundSterling2025-04-012026-03-3105542912ns10:Director12025-04-012026-03-3105542912ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3105542912ns10:SmallEntities2025-04-012026-03-3105542912ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-3105542912ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-3105542912ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3105542912ns10:FullAccounts2025-04-012026-03-3105542912ns10:Director22025-04-012026-03-3105542912ns10:CompanySecretary12025-04-012026-03-3105542912ns10:RegisteredOffice2025-04-012026-03-3105542912ns5:CurrentFinancialInstruments2026-03-3105542912ns5:CurrentFinancialInstruments2025-03-3105542912ns5:Non-currentFinancialInstruments2026-03-3105542912ns5:Non-currentFinancialInstruments2025-03-3105542912ns5:ShareCapital2026-03-3105542912ns5:ShareCapital2025-03-3105542912ns5:RetainedEarningsAccumulatedLosses2026-03-3105542912ns5:RetainedEarningsAccumulatedLosses2025-03-3105542912ns5:OwnedOrFreeholdAssetsns5:LandBuildings2025-04-012026-03-3105542912ns5:PlantMachinery2025-04-012026-03-3105542912ns5:FurnitureFittings2025-04-012026-03-3105542912ns5:LandBuildings2025-03-3105542912ns5:PlantMachinery2025-03-3105542912ns5:FurnitureFittings2025-03-3105542912ns5:MotorVehicles2025-03-3105542912ns5:LandBuildings2025-04-012026-03-3105542912ns5:MotorVehicles2025-04-012026-03-3105542912ns5:LandBuildings2026-03-3105542912ns5:PlantMachinery2026-03-3105542912ns5:FurnitureFittings2026-03-3105542912ns5:MotorVehicles2026-03-3105542912ns5:LandBuildings2025-03-3105542912ns5:PlantMachinery2025-03-3105542912ns5:FurnitureFittings2025-03-3105542912ns5:MotorVehicles2025-03-3105542912ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-3105542912ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3105542912ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2026-03-3105542912ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2025-03-31
REGISTERED NUMBER: 05542912 (England and Wales)



















Unaudited Financial Statements

for the Year Ended 31 March 2026

for

LONDON DERMATOLOGY LIMITED

LONDON DERMATOLOGY LIMITED (REGISTERED NUMBER: 05542912)

Contents of the Financial Statements
for the Year Ended 31 March 2026










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


LONDON DERMATOLOGY LIMITED

Company Information
for the Year Ended 31 March 2026







DIRECTORS: Dr. H P Stevens
Mrs D Stevens





SECRETARY: Mrs D Stevens





REGISTERED OFFICE: London Dermatology Limited
52 The Chase
Clapham Old Town
London
SW4 0NH





REGISTERED NUMBER: 05542912 (England and Wales)





ACCOUNTANTS: Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB

LONDON DERMATOLOGY LIMITED (REGISTERED NUMBER: 05542912)

Balance Sheet
31 March 2026

2026 2025
Notes £ £
FIXED ASSETS
Tangible assets 4 692,864 715,443

CURRENT ASSETS
Debtors 5 473,513 470,721
Cash at bank 9,443 5,708
482,956 476,429
CREDITORS
Amounts falling due within one year 6 (150,247 ) (151,536 )
NET CURRENT ASSETS 332,709 324,893
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,025,573

1,040,336

CREDITORS
Amounts falling due after more than
one year

7

-

(8,333

)
NET ASSETS 1,025,573 1,032,003

CAPITAL AND RESERVES
Called up share capital 1,000 1,000
Retained earnings 1,024,573 1,031,003
SHAREHOLDERS' FUNDS 1,025,573 1,032,003

LONDON DERMATOLOGY LIMITED (REGISTERED NUMBER: 05542912)

Balance Sheet - continued
31 March 2026


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 16 July 2026 and were signed on its behalf by:





Dr. H P Stevens - Director


LONDON DERMATOLOGY LIMITED (REGISTERED NUMBER: 05542912)

Notes to the Financial Statements
for the Year Ended 31 March 2026


1. STATUTORY INFORMATION

London Dermatology Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - 2% on cost
Office equipment - 25% on reducing balance
Fixtures and fittings - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

LONDON DERMATOLOGY LIMITED (REGISTERED NUMBER: 05542912)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026


2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2025 - 2 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Freehold Office and Motor
property equipment fittings vehicles Totals
£ £ £ £ £
COST
At 1 April 2025
and 31 March 2026 1,105,852 33,303 66,387 2,168 1,207,710
DEPRECIATION
At 1 April 2025 392,253 31,945 65,901 2,168 492,267
Charge for year 22,117 340 122 - 22,579
At 31 March 2026 414,370 32,285 66,023 2,168 514,846
NET BOOK VALUE
At 31 March 2026 691,482 1,018 364 - 692,864
At 31 March 2025 713,599 1,358 486 - 715,443

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£ £
Trade debtors 16,441 16,734
Amounts owed by group undertakings 448,099 448,000
Other debtors 4,654 3,614
Prepayments 4,319 2,373
473,513 470,721

LONDON DERMATOLOGY LIMITED (REGISTERED NUMBER: 05542912)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026


6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£ £
Bank loans and overdrafts 8,487 20,100
Trade creditors 13,017 6,009
Amounts owed to group undertakings 23,892 24,022
Social security and other taxes 698 1,469
Other creditors 17,060 17,060
Directors' current accounts 79,503 75,526
Accrued expenses 7,590 7,350
150,247 151,536

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2026 2025
£ £
Bank loans - 1-2 years - 8,333

8. ULTIMATE CONTROLLING PARTY

Dr H Stevens who is a director, and his family, own more than 50% of the share capital of London Dermatology Limited.